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Abstract 
A 45-year-old female presented with complaint of a lump in the right breast for the last 6 
months. Excisional biopsy had been performed outside our institution, which was 
suggestive of a pure mammary chondrosarcoma. Modified radical mastectomy of the 
right breast was performed and histopathology was suggestive of a pure mammary 
chondrosarcoma of the right breast. One axillary lymph node was positive for metastasis, 
the rest of the lymph nodes were free of metastasis. Immunohistochemistry was 
suggestive of a metaplastic carcinoma with a predominant chondrosarcoma in the right 
breast. Postoperative radiotherapy was given to the patient with a further plan of 
chemotherapy. 
Introduction 
Metaplastic carcinoma with predominant chondrosarcoma of the breast is exceedingly 
rare. Most benign and malignant tumors of the breast arise from the glandular 
epithelium. However, in some cases, the glandular epithelium differentiates into 
nonglandular mesenchymal tissue, a process called metaplasia [1]. Metaplastic changes, 
including squamous cell, spindle cell, and heterologous mesenchymal growth, occur in 
fewer than 5% of breast carcinomas [5]. Sarcomas of the breast are relatively rare, 
accounting for less than 1% of all primary malignant tumors of the female breast [2]. 
Carcinosarcomas, a subgroup of metaplastic carcinomas, are the rarest primary 
malignancies of the breast (found in <0.1% of cases) [3]. Metaplastic carcinomas are 
usually seen in women over 50 years of age. Here, we present a case of metaplastic 
carcinoma with predominant chondrosarcoma of the right breast with local single axillary 
lymph node metastasis. We report this case because of its rarity.   
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Case Report 
A 45-year-old female presented with complaint of a lump in the right breast for the last 6 months. 
On examination, there was a painless, freely mobile, hard lump of 7 × 5 cm in the right breast. The 
opposite breast and the axilla were normal. Hematological investigations were within normal limits, 
chest X-ray, ECG and heart and lung functions were normal. A surgical scar of a previous biopsy was 
present in the superolateral quadrant of the right breast. Excisional biopsy of the right breast lesion 
delivered the diagnosis of a pure mammary chondrosarcoma of the right breast, and fine needle 
aspiration cytology of the ipsilateral axillary lymph node was positive for malignancy. Modified radical 
mastectomy of the right breast with axillary dissection was done. The postoperative period was 
uneventful. 
On gross examination, the lesion was grayish white with areas of necrosis. Histopathology was 
suggestive of a pure mammary chondrosarcoma with all surgical margins free of tumor (fig. 1, fig. 2). 
One axillary lymph node mass (2.5 cm) was positive for metastasis. The remaining 4 axillary lymph 
nodes were free of tumor. Immunohistochemistry was suggestive of a poorly differentiated infiltrating 
duct carcinoma of the right breast with a dominant chondrosarcomatous component. Estrogen receptor 
(ER), progesterone receptor (PR), and c-erbB2 were negative. S-100 was positive in the metaplastic 
cartilaginous area, while tumor cells showed strong immunoreactivity for cytokeratins and epithelial 
membrane antigen in epithelial areas, which confirms the presence of metaplastic carcinoma with 
predominant chondrosarcoma with high-grade infiltrating duct carcinoma. Postoperative radiotherapy 
was given at 50 Gy/30 days, and the woman is on regular follow-up with a further treatment plan 
consisting of chemotherapy. 
Discussion 
Metaplastic breast carcinomas are regarded as ductal carcinomas
 that undergo 
metaplasia into a nonglandular growth pattern, and are difficult to accurately diagnose 
and classify because of their rarity and varied histological pattern. Tumors showing both 
carcinomatous and sarcomatous features are very uncommon and occur in various 
anatomical sites [4]. Metaplastic carcinomas of the breast are rare and interesting, yet 
confusing neoplasms. It has been reported that these tumors are more likely to occur in 
women over 50 years of age [5, 6, 9]. The patients usually describe a rapid growth with a 
short period of diagnosis. The tumors tend to have a circumscribed contour 
radiologically. A preoperative clinical and cytological diagnosis, though possible in a few 
cases, is usually not reached both due to marked similarity in clinical behavior and low 
index of suspicion. Classic sarcomatoid carcinoma is a tumor with both epithelial and 
mesenchymal components, hence the term biphasic sarcomatoid carcinoma. Carcinomas 
showing extensive metaplastic changes, including spindle cells, squamous cells and 
heterologous mesenchymal elements, are recognized in the breast [7]. In most of these 
cases, the infiltrating duct carcinoma is very small or focal or difficult to observe with 
routine HE stains or histopathological sections. Confirmation of epithelial 
(carcinomatous) component by immunohistochemical study is necessary in such cases to 
rule out pure primary mammary sarcomas. Metaplastic elements of pleomorphic spindle 
cells like fibrosarcoma, high-grade sarcomas, are rarely seen. However, chondrosarcoma, 
osteosarcoma and leiomyosarcoma components are extremely rare. In our case, the 
malignant chondrosarcomatous element was predominant; the infiltrating duct 
carcinoma was very focal and difficult to demonstrate in multiple histopathological 
sections. Therefore, we confirmed it by immunohistochemical study, which showed 
strong positivity for S-100 protein in chondromatous areas and focal positivity for 
cytokeratins and epithelial membrane antigen, while the tumor was negative for ER, PR 
and c-erbB2. 
The prognosis of patients with metaplastic breast carcinoma depends on the stage of 
disease, similar to that seen in invasive carcinomas of the breast [8, 9].  
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Tumor size is another prognostic factor. Patients with a tumor size not larger than 
5 cm have a better survival rate. Findings reported by Oberman [5], Kaufman et al. [6], 
and Chao et al. [9] suggest that the size of the neoplasm at the time of initial treatment 
best correlated with the prognosis. In our case, tumor size is larger than 5 cm, which is an 
unfavorable prognosis. 
The incidence of axillary lymph node metastasis is low in metaplastic carcinomas. Like 
invasive carcinomas of the breast, axillary lymph node metastasis in patients with 
metaplastic carcinoma correlates with poor prognosis [9, 10]. In our case, axillary lymph 
node metastasis was positive. The incidence of metastatic malignancy is very rare. One of 
these cases with pulmonary metastasis is reported by Beltaos et al. [2]. 
Metaplastic carcinoma rarely exhibits nuclear immunoreactivity for ER and PR [9]. 
Expression of markers 34BE12, p53, retinoblastoma protein, HER/2neu, epidermal 
growth factor receptor, and cyclin D1 does not correlate with clinicopathologic features 
such as patient age, tumor size, tumor type, and relative proportion of metaplastic 
elements [10]. 
Surgery remains the mainstay of treatment for most sarcomatoid tumors [11]. 
Multimodality treatment may decrease local and systemic recurrence rates of somatic 
sarcomas, but results are inconclusive in patients with breast sarcomas [11]. Surgical and 
adjuvant treatment should follow the guidelines for the other most common breast 
cancers even if the need for chemotherapy is unknown due to the absence of large series 
of randomized or observational data. 
We report on a case of metaplastic carcinoma with predominant chondrosarcoma with 
axillary metastasis. The patient is on regular follow-up on outpatient basis.  
There has been no evidence of local recurrence of the disease or distant metastasis. 
Regular follow-up of the patient is important for at least 5 years because recurrence rates 
are high. The overall 5-year disease-free survival rate is 43% in metaplastic breast 
carcinoma [12]. 
 
 
 
 
 
Fig. 1. Gross photograph of cut specimen of metaplastic breast carcinoma with predomiant 
chondrosarcoma. 
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Fig. 2. Microscopic photograph of metaplastic breast carcinoma with predominant chondrosarcoma 
(Hematoxylin & Eosin staining at 40× magnification). 
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